SCHEMBL16928591

SCHEMBL16928591

COc1ccc(Br)cc1/C=C/C(=O)c1c(O)cccc1OCc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 4/20 0.62
▸ PTPN1 P18031 1/20 0.55
▸ AR P10275 1/20 0.53
▸ TNFRSF1A P19438 1/20 0.50
▸ LMNA P02545 3/20 0.49
▸ PDE4A P27815 1/20 0.49
▸ PDE4B Q07343 1/20 0.49
▸ PDE4C Q08493 1/20 0.49
▸ PDE4D Q08499 1/20 0.49
▸ USP2 O75604 1/20 0.49
▸ MAOA P21397 1/20 0.49
▸ MAPT P10636 2/20 0.48
▸ HPGD P15428 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ ATM Q13315 1/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ AURKA O14965 1/20 0.47
▸ LRRK2 Q5S007 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16928594 1.00 MAOB (0.62) MAOBPTPN1ARTNFRSF1ALMNA
SCHEMBL16928592 0.88 MAOB (0.59) MAOBARLMNAMAOAMAPT
SCHEMBL16928593 0.88 MAOB (0.59) MAOBARLMNAMAOAMAPT
SCHEMBL15619200 0.87 MAOB (0.72) MAOBARTNFRSF1ALMNAMAOA
SCHEMBL15619199 0.87 MAOB (0.72) MAOBARTNFRSF1ALMNAMAOA
SCHEMBL16948578 0.85 MAOB (0.60) MAOBPTPN1ARTNFRSF1ALMNA
SCHEMBL25023075 0.82 PDE4A (0.71) MAOBPDE4APDE4BPDE4CPDE4D
SCHEMBL1727007 0.80 PTGER4 (0.52) MAOBPTPN1MAOA
SCHEMBL1727008 0.80 PTGER4 (0.52) MAOBPTPN1MAOA
SCHEMBL25201621 0.78 MAOB (0.65) MAOBMAOAMAPTATMCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9629822-B2 Flavonoid based antiviral targets UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2017-04-25 — — US disclosed
US-20150209323-A1 FLAVONOID BASED ANTIVIRAL TARGETS UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, (US) 2015-07-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150209323-A1 FLAVONOID BASED ANTIVIRAL TARGETS RBM28, MAVS, HAVCR2 MAOB 4153/4885PTPN1 3720/4885AR 4201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback